|
|
|
|
| LEADER |
02165nam a2200325 u 4500 |
| 001 |
EB001874764 |
| 003 |
EBX01000000000000001038131 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
191026 r ||| eng |
| 020 |
|
|
|a 9781926929309
|
| 245 |
0 |
0 |
|a Islet transplantation for the treatment of type 1 diabetes
|h Elektronische Ressource
|c Institute of Health Economics
|
| 260 |
|
|
|a Edmonton AB Canada
|b IHE, Institute of Health Economics
|c February 2013, 2013
|
| 300 |
|
|
|a 1 PDF file (xxi, 185 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Islets of Langerhans Transplantation / economics
|
| 653 |
|
|
|a Technology Assessment, Biomedical
|
| 653 |
|
|
|a Cost-Benefit Analysis
|
| 653 |
|
|
|a Diabetes Mellitus, Type 1 / surgery
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Alberta
|
| 710 |
2 |
|
|a Institute of Health Economics
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Alberta STE report
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK493548
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 580
|
| 082 |
0 |
|
|a 600
|
| 082 |
0 |
|
|a 330
|
| 520 |
|
|
|a This report is an update of the 2008 report on islet transplantation (IT) for Type 1 diabetes (T1DM). Section One of this analysis was intended to describe the profile of T1DM (definition, progression, epidemiology, and population dynamics of affected adults in Alberta, in Canada, and worldwide) and patterns of care for this condition in adults (focusing on recommendations from evidence-based guidelines), as well as to identify potential inequities in health status or care across adult population groups. Social, ethical, and legal issues associated with the provision of IT as a treatment for adults with T1DM were also considered. Section Two of the analysis was to determine, for the treatment of patients with T1DM in Alberta, the potential role of IT compared to whole pancreas transplantation or intensive insulin therapy (IIT). The objective of the economic analysis in Section Three was to estimate the costs and cost effectiveness of IT compared to IIT alone
|